Navroze Alphonse

Profile

Portfolio Manager with extensive experience running more than $1 billion GMV at large firms including Pictet Asset Management and Pequot Capital Management. Sector focus in healthcare with experience across all sub-sectors and specialization in medical devices and healthcare services. Experience running market-neutral long/short, traditional levered long/short, emerging markets, special situations, structured transaction and direct investment strategies. Leverages data analytics and financial modeling to optimize returns and identify emerging opportunities in global financial markets. Successful in marketing to institutional, endowment, sovereign wealth, and UHNW individual clients.

Senior Portfolio Manager, Candriam (Jun 2023 – Jan 2024, Brussels)

Lead portfolio manager, Candriam Equities L Lifecare Fund (CALLIUA.LX) — a $700 million ESG Article 8 global healthcare fund.

Managed all aspects of investment, team, internal portfolio construction, risk, and marketing.

Created presentations and update material; regularly communicated performance, positioning, and overall strategy to risk committee, management committee, and marketing professionals.

Senior Portfolio Manager, Global Equities – Healthcare, Pictet Asset Management (Feb 2021 – Feb 2023, Geneva)

Co-Head of a public-markets market-neutral global long/short healthcare fund actively managing a portfolio of global healthcare equities with over EUR 1 billion market exposure.

Responsible for evaluating, analyzing, initiating, and managing public-market healthcare investments in North America, Europe, and Asia.

Created custom derivative sub-sector hedge “baskets” to eliminate factor-based risk in portfolio sub-sectors.

Created presentations and update material; regularly communicated performance, positioning, and overall strategy.

Established relationships with brokers and service providers.

Conducted pre-IPO due diligence and communicated perspectives on positioning and valuation of potential IPO candidates across North America, Europe, and Asia; participated in IPO and secondary transactions across the healthcare sector.

Worked closely with thematic long-only portfolio managers to coordinate productive healthcare investment efforts across platforms.

Liaised with macro and generalist portfolio managers on the macro healthcare environment, trends, and investment ideas.

Served as primary pharmaceutical analyst, medical-technology analyst, and healthcare-services analyst.

Collaborated with the Head of total-return global equities healthcare to determine the thematic macro backdrop within sub-sectors and build a portfolio designed to capture secular tailwinds.

Structured and participated in complex secondary market transactions and financings; managed a team of sub-sector analysts.

Chief Investment Officer, Crossover Capital LLC (Jan 2012 – Oct 2020, New York)

Co-founded Crossover Healthcare LLC with Dr. Faraz Naqvi — an investment firm with a dual portfolio approach comprising a liquid long/short fund and an illiquid fund investing in private equity, small cap, distressed, and structured special situations.

Worked to discover, create, or develop the next generation of market leaders in pharmaceutical, biotechnology, medical device, and healthcare services companies, with the aim of making a meaningful contribution and positive social impact through the development of healthcare resources in target geographies.

Managing Director, Head of Public Healthcare Investments, Pequot Capital Management, LLC (Jan 2002 – Aug 2009, New York)

As of January 2006, responsible as co-portfolio manager and then sole portfolio manager for the $2 billion Pequot Healthcare Fund, Pequot Healthcare Offshore Fund, and Pequot Healthcare International Fund.

Responsible for evaluation, initiation, and hedging of public and private equity and credit investments in North America, Europe, and Asia.

Actively marketed the funds to institutional and individual clients and prospects in the U.S., Europe, Japan, and the Middle East, including Sovereign Funds, University Endowments, and State Pension Funds.

Managed a team that included four sector analysts, a research associate, and two dedicated traders.

Liaised with macro and generalist portfolio managers on the macro healthcare environment, trends, and investment ideas.

Identified healthcare as an under-developed investment sector in Emerging Markets including India, South Korea, Hong Kong, Singapore, Malaysia, Indonesia, Poland, Czech Republic, Hungary, and Croatia.

Conceptualized and leveraged the internal platform to create, raise, and launch the $200 million Pequot Emerging Markets Healthcare Fund — the first hedge fund dedicated to healthcare in the emerging markets.

Sourced and managed healthcare infrastructure and distressed investments in the United States and Asia.

Served as primary pharmaceutical analyst, biotechnology analyst, and healthcare-services analyst.

Joined in January 2003 as Vice President; promoted three times in three years, reaching Managing Director in December 2006.

Senior Analyst, Sands Point Capital Management LLC (Jan 2001 – Feb 2002, New York)

Senior analyst at a $250 million healthcare hedge fund, responsible for a portfolio of 80 equities across healthcare sub-sectors including domestic and international large-capitalization pharmaceuticals, specialty pharmaceuticals and generic drugs, healthcare services, biotechnology, and medical devices.

Featured Work & Expertise

Healthcare Long/Short

Pictet & Pequot

Co-Head of a EUR 1B+ market-neutral global healthcare fund at Pictet; previously sole portfolio manager of Pequot's $2B Healthcare Fund — running market-neutral, levered long/short, and emerging-markets strategies.

Emerging Markets Healthcare

First-of-Kind Fund

Conceptualized and launched the $200M Pequot Emerging Markets Healthcare Fund — the first hedge fund dedicated to healthcare in emerging markets, sourcing across India, Korea, Hong Kong, Singapore, and Central Europe.

Capital Formation

Sovereign & Endowment

Two decades marketing to sovereign wealth funds, university endowments, state pensions, and UHNW family offices across the US, Europe, Japan, and the Middle East — Columbia MBA, $1B+ GMV under management.